Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03509571 · ClinicalTrials.gov registry record · NA
Ketogenic Diet to Improve Neuro-recovery
A NA study of Spinal Cord Injuries, sponsored by Ohio State University.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT03509571: Recruiting NA study of Spinal Cord Injuries, sponsored by Ohio State University.
NCT03509571 is a NA study of Spinal Cord Injuries that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 60 participants, roughly in line with the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03509571, a NA study of Spinal Cord Injuries, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this project is to determine if 5 weeks of ketogenic (KD, high-fat) diet vs. standard diet (SD) significantly improves motor and sensory function, glycemic function, and functional independence in patients with spinal cord injury.
Primary Outcome
The ASIA Motor Index Score will be used for measuring motor function. This index uses standard manual muscle testing on a six grade scale. The total possible score from upper and lower extremity is 50. For the sensory examination, each dermatome will be tested for both sharp (pin-prick) and light-touch sensation and will be graded on a three point scale. Numerically, the sensory scores total 116 points. Measurement of motor and sensory function will take about an hour and will be performed 3 tim
Conditions Studied
Interventions
- OTHER Ketogenic Diet
- OTHER Standard Diet
Study Locations (1)
Ohio
- Ohio State University Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2019-05-09 |
| Est. Completion | 2026-01-01 |
| Phase | NA |
What NCT03509571 shows while recruiting
NCT03509571 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, roughly in line with the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target.
The record links to 1 condition, with Spinal Cord Injuries appearing as the primary indexed condition, and to 2 interventions - of which Ketogenic Diet is the first listed.
NCT03509571 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03509571 about?
NCT03509571 is a clinical study titled "Ketogenic Diet to Improve Neuro-recovery". The purpose of this project is to determine if 5 weeks of ketogenic (KD, high-fat) diet vs. standard diet (SD) significantly improves motor and sensory function, glycemic function, and functional independence in patients with spinal cord injury.
What is the current status of trial NCT03509571?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2019-05-09. Estimated completion is 2026-01-01.
What conditions does trial NCT03509571 study?
This clinical trial studies the following conditions: Spinal Cord Injuries.
What interventions are being tested in trial NCT03509571?
The interventions under investigation include: Ketogenic Diet (OTHER), Standard Diet (OTHER).
Who is sponsoring clinical trial NCT03509571?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03509571 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03509571's enrollment target sits among peer trials
60 48th of 202 higher than 145 of 202 other Spinal Cord Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Closed-loop Spinal Stimulation for Restoration of Upper Extremity Function After Spinal Cord Injury
RECRUITING · NA
-
Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury
RECRUITING · NA
-
Transcutaneous Spinal Stimulation and Exercise for Locomotion
RECRUITING · NA
-
HAPPINESS: cHAnging the Perceived Pain INtEnSity in Populations With Spinal Cord Injury and With Health Disparities: A Feasibility Study
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy